According to Harrow Health's latest financial reports and stock price the company's current Operating Margin is -12.93%. At the end of 2021 the company had an Operating Margin of -24.66%.
Year | Operating Margin | Change |
---|---|---|
2021 | -24.66% | 252.93% |
2020 | -6.99% | 2760.24% |
2019 | -0.24% | -100.69% |
2018 | 35.35% | -173.26% |
2017 | -48.26% | -49.87% |
2016 | -96.27% | -41.17% |
2015 | -163.64% | -73.15% |
2014 | -609.43% | -99.2% |
2013 | -76,431.24% | 1319.72% |
2012 | -5,383.54% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -36.36% | 181.21% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -8,391.15% | 64,796.75% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.